AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.
Ruderman
Neil
N
Department of Medicine, Boston University School of Medicine and Diabetes Unit, Section of Endocrinology, Boston Medical Center, 715 Albany Street, Boston, Massachusetts 02118, USA. nruderman@medicine.bu.edu
Prentki
Marc
M
D000263:Adenylate Kinase / Q000378:metabolism*; D000818:Animals; D005227:Fatty Acids / Q000378:metabolism*; D006801:Humans; D008316:Malonyl Coenzyme A / Q000378:metabolism*; D024821:Metabolic Syndrome / Q000201:enzymology / Q000473:pathology / Q000628:therapy*; D015398:Signal Transduction
D005227:Fatty Acids; D008316:Malonyl Coenzyme A; D000263:Adenylate Kinase